Alian Aguila, MD, is board certified in cardiovascular medicine, internal medicine and cardiac imaging modalities including echocardiography, nuclear cardiology, and cardiac CT Tomography. Dr. Aguila earned his medical degree in 2008 at the University of Miami Miller School of Medicine in Miami. He completed an internship in internal medicine in 2009 at the University of Rochester School of Medicine, where he also completed his residency in internal medicine in 2011. He then completed his fellowship in cardiovascular disease in 2014 at the University of Florida School of Medicine.

In 2015, Dr. Aguila joined Memorial Cardiac and Vascular Institute and Memorial Physician Group in the Division of Cardiac Services.

Hospital Affiliations

• Memorial Hospital Pembroke
• Memorial Hospital West
• Memorial Regional Hospital

Gender

• Male

Languages

• Spanish
• Portuguese

Education

University Of Miami Medical School, 2008

Internships

University Of Rochester, 2009, Internal Medicine

Residency

University Of Rochester, 2011, Internal Medicine

Fellowships

Shands Hospital At The University Of Florida, 2014, Cardiovascular Disease

Certifications

American Board of Internal Medicine-Cardiovascular Disease
American Board of Internal Medicine-Internal Medicine

Publications

• View Dr. Alian Aguila's publications on PubMed 

Research

• Ranolazine Implantable Cardioverter-Defibrillator (RAID) Trial NCT 01215253. Co-investigator. Principal Investigators: Wojciech Zareba MD and Arthur Moss MD. (2012–2014)
• University of Rochester Medical Center Cardiology Department. Principal Investigators: James P Daubert MD and Mehmet K Aktas MD (2008–2011)
• Summer Internship at National Institutes of Health and National Cancer Institute. Maryland. Principal Investigator: Antonio Tito Fojo MD, PhD. (2005)
• CRTA Fellow at National Institutes of Health and National Cancer Institute. Maryland. Principal Investigator: Antonio Tito Fojo MD, PhD. (2003–2004)
• Summer Internship at National Institutes of Health and National Center for Complementary and Alternative Medicine. Maryland. Principal Investigator: Mark R Blackman MD. (2003)
• NIH/NIGMS MARC-U-STAR Research Training. Florida. Principal Investigator: Kalai Mathee PhD. (2001–2003)

Abstracts and Presentations

• Aguila A, Aktas MK, Funderburk M, Mcnitt S, Delehanty JM, Traub DM and Daubert JP. Outcomes following therapeutic hypothermia for patients presenting with cardiac arrest. Heart Rhythm Society Annual Meeting: poster abstract # 107. Boston, Massachusetts 2009.
• Aktas MK, Aguila A, Daniels LA, Hinkle AS, Meagher CC, Alfieris GM and Daubert JP .Therapeutic Hypothermia in Seven Year Old Patient with Long QT Syndrome and Cardiac Arrest. Heart Rhythm Society Annual Meeting: poster abstract # 171. Boston, Massachusetts 2009.
• Kong KF, Aguila A, Narasimhan G, Park J, Uehara T, Merighi M, Balasubramanian D, Lory S and Mathee K. Toward the Understanding of the mechanism of ß-lactamase induction in Pseudomonas aeruginosa. Meeting of the Cold Spring Harbor Laboratory on Microbial Pathogenesis and Host Response. Abstract # 88. Cold Spring Harbor, NY 2007
• Murphy RF, Farrell N, Aguila A, Osada M, Balis FM and Fojo T. Accumulation of Novel Transplatinum Complexes in Cisplatin and Oxaliplatin Resistant Cell Lines Overcomes Resistance. American Association for Cancer Research Annual Meeting: poster abstract # 4109. Anaheim, California 2005
• Goldsmith ME, Aguila A, Alley MC, Waud WR, Bates S and Fojo T. The histone deacetylase inhibitor FK228 can increase adenovirus transgene expression in human LOX IMVI melanoma xenografts. American Association for Cancer Research Annual Meeting: poster abstract # 1344. Anaheim, California 2005.
• Aguila A, Goldsmith ME, Gollapalli SJ, Alley MC, Waud WW, Bates S and Fojo T. Coxsackie-adenovirus receptor (CAR) levels can be increased in human xenografts followed by treatment with FK228, a histone deacetylase inhibitor. American Society of Gene Therapy 7th Annual Meeting: poster abstract # 618. Minneapolis, Minnesota 2004.
• Aguila A, Arnold JT and Blackman MR. DHEA effects in prostate stromal and cancer cells. National Institutes of Health Summer Poster Sessions: poster abstract # 99. Bethesda, Maryland 2003.
• Aguila A. Pseudomonas aeruginosa AmpG, a putative permease involved in β-lactam antibiotic resistance. Undergraduate Honor Thesis. Florida International University. Miami, Florida 2003.
• Aguila A, Kong KF and Mathee K. Topology Analysis of Pseudomonas aeruginosa AmpG, a putative permease involved in β-lactam antibiotic resistance. American Society of Microbiology- Annual Biomedical Research Conference for Minority Students: poster abstract # 777. New Orleans, Louisiana 2002.

Professional Organizations

• American College of Cardiology
• American College of Physicians
• American Medical Association
• Phi Beta Kappa

Awards

• Honors College Alumni
• Phi Beta Kappa Honors Society
• Bachelors of Science with Honors Summa Cum laude
• Florida International University Award for Outstanding Scholastic Achievement in Biology
• National Institutes of Health Cancer Research Training Award
• National Institutes of Health /NIGMS MARC-U-STAR Research Training Award
• University of Miami Leonard M Miller School of Medicine Scholarship
• University of Rochester School of Medicine Raphael Dolin Resident Research Award